Nuclear Regulation Mapping of m6A and its regulatory targets in prostate cancer shows low METTL3 induction of therapy… Carmen Lillard Jun 6, 2021 Mapping of m6A and its regulatory targets in prostate cancer shows a low METTL3 induction of therapy resistance DocWire News
Nuclear Regulation The pooled CRISPR screening identifies m6A as a positive regulator of macrophage activation –… Carmen Lillard Apr 28, 2021 The pooled CRISPR screening identified m6A as a positive regulator of macrophage activation Science Advances